Important topics for neet pg
NEET PG 2025 2026 important topics high yield subject wise weightage
NEET PG previous year question paper topic wise analysis 2023 2024
50% questions are image-linked (radiology, histology, clinical photos)
| Subject | 2023 | 2024 (S1) | 2024 (S2) | 2025 | 2026 Est. |
|---|---|---|---|---|---|
| Medicine (incl. Derm, Psych) | 13 | 17 | 17 | 30 | 21 |
| Surgery | ~22 | ~20 | ~18 | 18 | 23 |
| OBGYN | ~15 | ~16 | ~16 | 20 | 19 |
| Community Medicine/PSM | 16 | 22 | 15 | 16 | 15 |
| Pathology | 18 | 16 | 21 | 12 | 14 |
| Pharmacology | 12 | 8 | 18 | 15 | 14 |
| Biochemistry | 13 | 14 | 9 | 15 | 13 |
| Microbiology | 16 | 8 | 8 | 12 | 12 |
| Anatomy | 7 | 7 | 16 | 9 | 9 |
| Physiology | 9 | 6 | 6 | 5 | 7 |
| Forensic Medicine | 10 | 9 | 4 | 6 | 6 |
| Ophthalmology | 7 | 11 | 8 | 5 | 6 |
| ENT | 6 | 11 | 6 | 5 | 5 |
| Orthopedics | ~8 | ~7 | ~7 | 5 | 6 |
| Pediatrics | ~8 | ~8 | ~8 | 5 | 6 |
| Dermatology | - | - | - | 8 | 6 |
| Radiology | - | - | - | 5 | 4 |
| Anesthesia | - | - | - | 4 | 3 |
Top 5 subjects = ~50% of paper: OBG + Medicine + Microbiology + Surgery + Physiology (2025 trend)
| Condition | Drug |
|---|---|
| TB - first line | HRZE (Rifampicin + INH + Pyrazinamide + Ethambutol) |
| Community-acquired pneumonia | Amoxicillin/Azithromycin |
| Eclampsia | MgSO4 |
| Status epilepticus | IV Lorazepam → Phenytoin → Phenobarbital |
| Falciparum malaria | Artesunate |
| Typhoid | Ceftriaxone (or Azithromycin) |
| H. pylori | Triple therapy (PPI + Clarithromycin + Amoxicillin) |
| Organophosphate poisoning | Atropine + Pralidoxime |
| Opioid overdose | Naloxone |
| Heparin overdose | Protamine sulfate |
| DM with nephropathy (HTN) | ACE inhibitor |
| Heart failure (EF reduced) | ACEi/ARB + Beta-blocker + Spironolactone |
| Condition | Appearance | Cells | Protein | Glucose |
|---|---|---|---|---|
| Bacterial meningitis | Turbid | ↑ PMN | ↑↑ | ↓↓ |
| Viral meningitis | Clear | ↑ Lymph | ↑ | Normal |
| TB meningitis | Cobweb | ↑ Lymph | ↑↑↑ | ↓ |
| Fungal | Clear | ↑ Lymph | ↑ | ↓ |
| Normal | Clear | 0-5 Lymph | 20-40 mg/dL | 60-80% plasma |
| Priority | Action |
|---|---|
| #1 | Build a master Drug of Choice list across all subjects |
| #2 | Image-based preparation - radiology, histology, fundoscopy, skin lesions |
| #3 | Do all PYQs (2019-2025) - ~40% questions repeat or are conceptually similar |
| #4 | Focus on clinical stems - every question has a patient scenario |
| #5 | PSM + Biochemistry = high repeat rate, high ROI for time invested |
| #6 | Avoid ultra-rare topics in low-yield subjects in the final 2 months |
Key insight for 2026: The paper is shifting toward integrated clinical reasoning - you need to know not just the diagnosis but also mechanism, investigation of choice, and first-line management together. Pure rote recall is no longer sufficient.